318 related articles for article (PubMed ID: 30129441)
1. Quality of Life of Food-Allergic Patients Before, During, and After Oral Immunotherapy.
Epstein-Rigbi N; Goldberg MR; Levy MB; Nachshon L; Elizur A
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):429-436.e2. PubMed ID: 30129441
[TBL] [Abstract][Full Text] [Related]
2. Changes in patient quality of life during oral immunotherapy for food allergy.
Rigbi NE; Goldberg MR; Levy MB; Nachshon L; Golobov K; Elizur A
Allergy; 2017 Dec; 72(12):1883-1890. PubMed ID: 28542911
[TBL] [Abstract][Full Text] [Related]
3. Quality of life of children aged 8-12 years undergoing food allergy oral immunotherapy: Child and parent perspective.
Epstein-Rigbi N; Goldberg MR; Levy MB; Nachshon L; Elizur A
Allergy; 2020 Oct; 75(10):2623-2632. PubMed ID: 32350869
[TBL] [Abstract][Full Text] [Related]
4. Patient quality of life following induction of oral immunotherapy for food allergy.
Epstein Rigbi N; Katz Y; Goldberg MR; Levy MB; Nachshon L; Elizur A
Pediatr Allergy Immunol; 2016 May; 27(3):263-8. PubMed ID: 26681071
[TBL] [Abstract][Full Text] [Related]
5. Medical clown support is associated with better quality of life of children with food allergy starting oral immunotherapy.
Epstein Rigbi N; Schwartz N; Goldberg MR; Levy MB; Nachshon L; Elizur A
Pediatr Allergy Immunol; 2021 Jul; 32(5):1029-1037. PubMed ID: 33452829
[TBL] [Abstract][Full Text] [Related]
6. Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial.
Reier-Nilsen T; Carlsen KCL; Michelsen MM; Drottning S; Carlsen KH; Zhang C; Borres MP; Håland G
Pediatr Allergy Immunol; 2019 Sep; 30(6):638-645. PubMed ID: 31013372
[TBL] [Abstract][Full Text] [Related]
7. Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy.
Shin S; Jang S; Kim J; Song J; Park S; Kim Y; Lee MH; Kim HM; Choi YR; Jung M; Kim M; Lee JY; Baek J; Kim S; Kim J; Ahn K
Allergy Asthma Proc; 2024 Mar; 45(2):128-136. PubMed ID: 38449018
[No Abstract] [Full Text] [Related]
8. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
Blumchen K; Trendelenburg V; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Holzhauser T; Roeder M; Rosenfeld L; Hartmann O; Niggemann B; Beyer K
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):479-491.e10. PubMed ID: 30423449
[TBL] [Abstract][Full Text] [Related]
9. Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies.
DunnGalvin A; Fleischer DM; Campbell DE; O'B Hourihane J; Green TD; Sampson HA; Greenhawt M
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):216-224.e1. PubMed ID: 32841748
[TBL] [Abstract][Full Text] [Related]
10. Development of an Oral Immunotherapy-Related Parental Burden Scale.
Maeta A; Takaoka Y; Hamada M; Nakano A; Sumimoto S; Anzai K; Tanaka Y; Morikawa S; Kameda M; Takahashi K
Int Arch Allergy Immunol; 2023; 184(12):1203-1215. PubMed ID: 37647864
[TBL] [Abstract][Full Text] [Related]
11. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.
Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940
[TBL] [Abstract][Full Text] [Related]
12. Safety of Multifood Oral Immunotherapy in Children Aged 1 to 18 Years at an Academic Pediatric Clinic.
Nguyen K; Lewis MO; Hanna E; Alfaro MKC; Corrigan K; Buonanno J; Datta R; Brown-Whitehorn T; Spergel JM; Cianferoni A
J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1907-1913.e1. PubMed ID: 36907355
[TBL] [Abstract][Full Text] [Related]
13. Impact of oral immunotherapy on quality of life in children with cow milk allergy: a pilot study.
Carraro S; Frigo AC; Perin M; Stefani S; Cardarelli C; Bozzetto S; Baraldi E; Zanconato S
Int J Immunopathol Pharmacol; 2012; 25(3):793-8. PubMed ID: 23058033
[TBL] [Abstract][Full Text] [Related]
14. Validation and reliability of the Japanese version of the Food Allergy Quality of Life Questionnaire-Parent Form.
Mizuno Y; Ohya Y; Nagao M; DunnGalvin A; Fujisawa T
Allergol Int; 2017 Apr; 66(2):290-295. PubMed ID: 27599914
[TBL] [Abstract][Full Text] [Related]
15. Food allergy QoL questionnaire for children aged 0-12 years: content, construct, and cross-cultural validity.
DunnGalvin A; de BlokFlokstra BM; Burks AW; Dubois AE; Hourihane JO
Clin Exp Allergy; 2008 Jun; 38(6):977-86. PubMed ID: 18435800
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab.
Yee CSK; Albuhairi S; Noh E; El-Khoury K; Rezaei S; Abdel-Gadir A; Umetsu DT; Burke-Roberts E; LeBovidge J; Schneider L; Rachid R
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):451-461.e7. PubMed ID: 30267889
[TBL] [Abstract][Full Text] [Related]
17. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
Scurlock AM
Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
[TBL] [Abstract][Full Text] [Related]
18. Safety and Effectiveness of Bypassing Oral Immunotherapy Buildup With an Initial Phase of Sublingual Immunotherapy for Higher-Risk Food Allergy.
Soller L; Williams BA; Mak R; Wong T; Erdle SC; Chomyn A; Tetreault B; Morrison K; Gaudet L; Chan ES
J Allergy Clin Immunol Pract; 2024 May; 12(5):1283-1296.e2. PubMed ID: 38423293
[TBL] [Abstract][Full Text] [Related]
19. Oral Immunotherapy for Food Allergy: A Spanish Guideline. Egg and Milk Immunotherapy Spanish Guide (ITEMS GUIDE). Part II: Maintenance Phase of Cow Milk (CM) and Egg Oral Immunotherapy (OIT), Special Treatment Dosing Schedules. Models of Dosing Schedules of OIT With CM and Egg.
Martorell A; Alonso E; Echeverría L; Escudero C; García-Rodríguez R; Blasco C; Bone J; Borja-Segade J; Bracamonte T; Claver A; Corzo JL; De la Hoz B; Del Olmo R; Dominguez O; Fuentes-Aparicio V; Guallar I; Larramona H; Martín-Muñoz F; Matheu V; Michavila A; Ojeda I; Ojeda P; Piquer M; Poza P; Reche M; Rodríguez Del Río P; Rodríguez M; Ruano F; Sánchez-García S; Terrados S; Valdesoiro L; Vazquez-Ortiz M;
J Investig Allergol Clin Immunol; 2017; 27(5):279-290. PubMed ID: 28593864
[TBL] [Abstract][Full Text] [Related]
20. Oral immunotherapy for peanut allergy: The pro argument.
Chinthrajah RS; Cao S; Dunham T; Sampath V; Chandra S; Chen M; Sindher S; Nadeau K
World Allergy Organ J; 2020 Aug; 13(8):100455. PubMed ID: 33005286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]